Taken together, these results support the idea that RECK-inducibility, as predicted by RPM, may be useful in predicting effectiveness of certain drugs, especially those activating RECK expression, in suppressing malignant growth and behaviors of breast cancer cells. Here, RECK is linked to breast carcinoma.